BackgroundPerformance status (PS) is an important factor in determining survival outcome in non-small cell lung cancer (NSCLC) but is generally confounded by stage, age, gender, and smoking status. We investigated the prognostic significance of PS taking into account these important factors.MethodsRetrospective analysis of registry database of the National Hospital Study Group for Lung Cancer (NHSGLC) between1990 and 2005. Univariate analysis was performed using Kaplan-Meier method. Multivariate analysis was performed using Cox proportional hazards model to identify independent prognostic factors.ResultsA total of 26,957 patients with NSCLC were analyzed of which 12,613 patients (46.8%) had World Health Organization (WHO) PS = 0, 8,137 pati...
The FLEX study demonstrated that the addition of cetuximab to chemotherapy significantly improved ov...
Background: There is a lack of tools for selecting patients with advanced lung cancer who benefit th...
Lung cancer is the leading cause of cancer-related mortality in both genders worldwide. Non-small ce...
BackgroundPerformance status (PS) is an important factor in determining survival outcome in non-smal...
Identifying strong markers of prognosis is critical to optimize treatment and survival outcomes in p...
AIMS: Performance status (PS) is commonly used for patient stratification in lung cancer clinical tr...
Performance status (PS) is a commonly used factor in determining the appropriateness for chemotherap...
BackgroundThere has been a growing interest in lung cancer in never-smokers.MethodsUtilizing a datab...
Background:We investigated whether independent prognostic factors for overall survival (OS) in non-s...
ABSTRACT-The 12-month survival of 223 women with primary lung cancer was examined according to their...
PurposeTo identify, in the international staging database of the International Association for the S...
AbstractObjectivesIn patients with advanced incurable lung cancer deciding as to the most appropriat...
  Objective: Adenocarcinoma (AC) of the lung is now the most common histologic type of non-small c...
Introduction:The purposes of this study are to investigate the association between cigarette smoking...
Purpose:To assess the impact of cell type, age, and gender in addition to pathologic tumor, node, me...
The FLEX study demonstrated that the addition of cetuximab to chemotherapy significantly improved ov...
Background: There is a lack of tools for selecting patients with advanced lung cancer who benefit th...
Lung cancer is the leading cause of cancer-related mortality in both genders worldwide. Non-small ce...
BackgroundPerformance status (PS) is an important factor in determining survival outcome in non-smal...
Identifying strong markers of prognosis is critical to optimize treatment and survival outcomes in p...
AIMS: Performance status (PS) is commonly used for patient stratification in lung cancer clinical tr...
Performance status (PS) is a commonly used factor in determining the appropriateness for chemotherap...
BackgroundThere has been a growing interest in lung cancer in never-smokers.MethodsUtilizing a datab...
Background:We investigated whether independent prognostic factors for overall survival (OS) in non-s...
ABSTRACT-The 12-month survival of 223 women with primary lung cancer was examined according to their...
PurposeTo identify, in the international staging database of the International Association for the S...
AbstractObjectivesIn patients with advanced incurable lung cancer deciding as to the most appropriat...
  Objective: Adenocarcinoma (AC) of the lung is now the most common histologic type of non-small c...
Introduction:The purposes of this study are to investigate the association between cigarette smoking...
Purpose:To assess the impact of cell type, age, and gender in addition to pathologic tumor, node, me...
The FLEX study demonstrated that the addition of cetuximab to chemotherapy significantly improved ov...
Background: There is a lack of tools for selecting patients with advanced lung cancer who benefit th...
Lung cancer is the leading cause of cancer-related mortality in both genders worldwide. Non-small ce...